HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yujie Fu Selected Research

cajanol

12/2013The phytoestrogenic compound cajanol from Pigeonpea roots is associated with the activation of estrogen receptor α-dependent signaling pathway in human prostate cancer cells.
10/2010Cajanol, a novel anticancer agent from Pigeonpea [Cajanus cajan (L.) Millsp.] roots, induces apoptosis in human breast cancer cells through a ROS-mediated mitochondrial pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yujie Fu Research Topics

Disease

29Neoplasms (Cancer)
01/2022 - 11/2006
10Breast Neoplasms (Breast Cancer)
01/2019 - 04/2010
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2021 - 03/2016
4Lung Neoplasms (Lung Cancer)
12/2020 - 01/2016
4Neoplasm Metastasis (Metastasis)
07/2019 - 02/2016
3Infections
11/2021 - 03/2010
2Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 07/2013
2Carcinogenesis
01/2021 - 01/2014
2Brain Neoplasms (Brain Tumor)
01/2020 - 07/2016
2Insulin Resistance
06/2019 - 11/2018
2Type 2 Diabetes Mellitus (MODY)
06/2019 - 11/2018
2Prostatic Neoplasms (Prostate Cancer)
01/2019 - 12/2013
2Leukemia
12/2009 - 08/2009
2T-Cell Leukemia (Leukemia, T Cell)
12/2009 - 08/2009
1Sarcoma (Soft Tissue Sarcoma)
01/2022
1Ovarian Epithelial Carcinoma
01/2022
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
10/2021
1Bacterial Infections (Bacterial Infection)
10/2021
1Metabolic Diseases (Metabolic Disease)
10/2021
1Obesity
10/2021
1Mycoses (Diseases, Fungus)
01/2021
1Fistula
12/2020
1Hypoxia (Hypoxemia)
01/2020
1Periapical Periodontitis (Apical Periodontitis)
01/2020
1Chronic Disease (Chronic Diseases)
07/2019
1Cardiomegaly (Heart Hypertrophy)
07/2019
1Fibrosis (Cirrhosis)
07/2019
1Dyslipidemias (Dyslipidemia)
06/2019
1Hyperglycemia
06/2019
1Macular Degeneration (Age-Related Maculopathy)
01/2019
1Autosomal Dominant 5 Deafness
12/2018
1Inflammation (Inflammations)
11/2018

Drug/Important Bio-Agent (IBA)

4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 10/2014
43- hydroxy- 4- prenyl- 5- methoxystilbene- 2- carboxylic acidIBA
03/2016 - 10/2014
3LipidsIBA
01/2022 - 06/2019
3Estrogen ReceptorsIBA
11/2015 - 12/2013
3Antiviral Agents (Antivirals)IBA
01/2011 - 01/2010
2Glutathione (Reduced Glutathione)IBA
01/2022 - 01/2020
21-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2022 - 01/2020
2Photosensitizing Agents (Photosensitizers)IBA
01/2022 - 01/2020
2Deubiquitinating EnzymesIBA
11/2021 - 01/2021
2Biological ProductsIBA
03/2020 - 01/2019
2CateninsIBA
01/2020 - 01/2014
2Emodin (Archin)IBA
07/2019 - 06/2019
2Pharmaceutical PreparationsIBA
12/2018 - 03/2015
2EpitopesIBA
12/2016 - 11/2011
2Interleukin-6 (Interleukin 6)IBA
05/2016 - 01/2016
2isoliquiritigenin (GU 17)IBA
10/2014 - 08/2009
2cajanolIBA
12/2013 - 10/2010
1Messenger RNA (mRNA)IBA
01/2022
1Tumor Biomarkers (Tumor Markers)IBA
01/2022
1Chelating AgentsIBA
01/2022
1human ERBB2 proteinIBA
01/2022
1Radioisotopes (Radionuclides)IBA
01/2022
1Molecular Probes (Molecular Probe)IBA
01/2022
1FlavonoidsIBA
11/2021
1AluminumIBA
01/2021
1LigandsIBA
01/2021
1MetalsIBA
01/2021
1B7-H1 AntigenIBA
12/2020
1Immune Checkpoint InhibitorsIBA
12/2020
1pembrolizumabIBA
12/2020
1PlatinumIBA
12/2020
1Competitive Endogenous RNAIBA
03/2020
1Circular RNAIBA
03/2020
1Contrast MediaIBA
01/2020
1BerberineIBA
01/2020
1SilicatesIBA
01/2020
1Calcium HydroxideIBA
01/2020
1Proteins (Proteins, Gene)FDA Link
07/2019
1Angiotensin IIIBA
07/2019
1Glucose (Dextrose)FDA LinkGeneric
06/2019
1Blood Glucose (Blood Sugar)IBA
06/2019
1AlbuminsIBA
01/2019
1Docetaxel (Taxotere)FDA Link
01/2019
1LuteinIBA
01/2019
1Caspase 3 (Caspase-3)IBA
12/2018
1Peptide Hydrolases (Proteases)FDA Link
12/2018
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
11/2018
1Glucose Transporter Type 4IBA
11/2018
1Phosphotransferases (Kinase)IBA
10/2018
1Neoplasm Antigens (Tumor Antigens)IBA
12/2016
1AntigensIBA
12/2016
1Telomerase (Telomerase Reverse Transcriptase)IBA
07/2016
1MicroRNAs (MicroRNA)IBA
03/2016
1bleomycin A6IBA
02/2016
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2016
1TamoxifenFDA LinkGeneric
11/2015
1PhytochemicalsIBA
04/2015
1Peptides (Polypeptides)IBA
03/2015

Therapy/Procedure

7Therapeutics
01/2022 - 04/2015
4Drug Therapy (Chemotherapy)
12/2020 - 04/2015
3Precision Medicine
01/2022 - 01/2020
2Photochemotherapy (Photodynamic Therapy)
01/2022 - 01/2020
2Immunotherapy
02/2021 - 01/2020
2Chinese Traditional Medicine (Traditional Chinese Medicine)
10/2010 - 01/2010
1Chest Tubes (Chest Tube)
11/2021
1Traditional Medicine (Folk Remedies)
10/2021
1Neoadjuvant Therapy
12/2020
1Molecular Targeted Therapy
12/2018